Yibei Dai

机构：Nanfang Hospital, Second Affiliated Hospital of Zhejiang University, Southern Medical University · ORCID：0000-0001-6863-3988

发表论文 32 篇 · 总被引 590 次 · h-index 12

代表论文

• DPHL: A DIA Pan-Human Protein Mass Spectrometry Library for Robust Biomarker Discovery (2020 · Genomics Proteomics & Bioinformatics · 被引 99)
• Emerging roles and mechanisms of microRNA‑222‑3p in human cancer (Review) (2021 · International Journal of Oncology · 被引 45)
• Glycolysis-related gene expression profiling serves as a novel prognosis risk predictor for human hepatocellular carcinoma (2021 · Scientific Reports · 被引 44)
• Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients (2019 · International Journal of Oncology · 被引 23)
• A Multivariate Diagnostic Model Based on Urinary EpCAM-CD9-Positive Extracellular Vesicles for Prostate Cancer Diagnosis (2021 · Frontiers in Oncology · 被引 21)
• Serum oncostatin M is a potential biomarker of disease activity and infliximab response in inflammatory bowel disease measured by chemiluminescence immunoassay (2021 · Clinical Biochemistry · 被引 17)